$1.36
+0.01 (+0.74%)
Open$1.35
Previous Close$1.35
Day High$1.40
Day Low$1.33
52W High$3.52
52W Low$1.27
Volume—
Avg Volume143.7K
Market Cap48.14M
P/E Ratio8.22
EPS$0.11
SectorPharmaceuticals
Analyst Ratings
Strong Buy
11 analysts
Price Target
+1,128.7% upside
Current
$1.36
$1.36
Target
$16.71
$16.71
$12.81
$16.71 avg
$20.08
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 180.27M | 171.33M | 22.38M |
| Net Income | 25.36M | 21.70M | 3.27M |
| Profit Margin | 14.1% | 13.4% | 14.6% |
| EBITDA | 35.22M | 31.80M | 5.70M |
| Free Cash Flow | — | — | 2.62M |
| Rev Growth | +5.2% | +5.2% | -5.1% |
| Debt/Equity | 9.02 | 9.02 | 0.18 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |